News & Views

From research findings supporting SGLT-2 inhibitors as a first-choice type 2 treatment to a real-world study strengthening evidence for teplizumab in early type 1, here are some of the diabetes research developments announced in February 2026.

Read more
Show me:
Showing 800 articles
Image
News placeholder image
20.04.2021

DUKPC research highlights: Day 2

On day two of our professional conference (DUKPC), fibre was in the spotlight and we heard about new rese...
Image
News placeholder image
19.04.2021

DUKPC research highlights: Day 1

We’ve just kicked off our annual professional conference (DUKPC). It sees hundreds of healthcare professi...
Back to Top
Brand Icons/Telephone check - FontAwesome icons/tick icons/uk